Michael Bradley, MD
Orthopaedic Surgery · Wakefield, RINPI 1083668883
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (42.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Arthrex accounts for 63.2% of it on its own, with 19 other manufacturers making up the rest. Among orthopaedic surgery clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 607 payments — averaging $2243.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$860K
- FX Shoulder Solutions, Inc$183K
- Corin USA$98K
- Omnilife Science, Inc$80K
- Encore Medical, LP$59K
- Intellijoint Surgical Inc.$59K
- plus $23K from 14 others
Across 27 payments — averaging $6553.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- FX Shoulder Solutions, Inc$154K
- Illuminoss Medical, Inc.$12K
- Arthrex$11K
Across 3 payments — averaging $62,998 each. An ownership or investment interest held by the physician or an immediate family member.
- Omnilife Science, Inc$164K
- Intellijoint Surgical Inc.$25K
What the payments were for
- Royalty or licence$583,41643%
- Consulting fees$371,40927%
- Speaking & faculty fees$311,03923%
- Travel & lodging$84,4006%
- Food & beverage$11,2281%
- Gifts$1140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 356 | $860,191 |
| FX Shoulder Solutions, Inc | 20 | $182,704 |
| Corin USA | 45 | $97,828 |
| Omnilife Science, Inc | 112 | $79,850 |
| Encore Medical, LP | 32 | $59,256 |
| Intellijoint Surgical Inc. | 7 | $59,104 |
| Naviswiss, Inc. | 10 | $21,105 |
| Kairos Surgical Inc | 5 | $848 |
| Stryker | 4 | $269 |
| Bioventus LLC | 4 | $128 |
| Engage Uni, LLC | 1 | $114 |
| Illuminoss Medical, Inc. | 3 | $48 |
| Vertex | 1 | $32 |
| EBI, LLC | 1 | $24 |
| Acera Surgical, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Orthofix Medical, Inc. | 1 | $18 |
| Davol Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHREX$1,108,847
- ARTHROPLASTY IMPLANTS KNEE ARTHROPLASTY TOTAL KNEE$102,870
- ARTHROPLASTY IMPLANTS KNEE ARTHROPLASTY PATELLO FEMORAL$102,870
- ARTHROPLASTY INSTRUMENTS KNEE ARTHROPLASTY TOTAL KNEE$102,870
- ARTHROPLASTY INSTRUMENTS KNEE ARTHROPLASTY PATELLO FEMORAL$102,870
- KNEE & HIP IMPLANTS PATELLOFEMORAL OTHER$81,025
- ARTHROPLASTY INSTRUMENTS SHOULDER ARTHROPLASTY & FRACTURE REVERS$70,760
- Intellijoint HIP$59,104
- ARTHROPLASTY IMPLANTS KNEE & HIP ARTHROPLASTY TOTAL KNEE$48,915
- ARTHROPLASTY IMPLANTS KNEE & HIP ARTHROPLASTY PATELLO FEMORAL$48,915
- ARTHROPLASTY INSTRUMENTS KNEE & HIP ARTHROPLASTY TOTAL KNEE$48,915
- ARTHROPLASTY INSTRUMENTS KNEE & HIP ARTHROPLASTY PATELLO FEMORAL$48,915
- FX V 135 stem$43,585
- ARTHROPLASTY IMPLANTS TOTAL KNEE ARTHROPLASTY TOTAL KNEE$33,273
- ARTHROPLASTY IMPLANTS PARTIAL KNEE ARTHROPLASTY PATELLO FEMORAL$33,273
- ARTHROPLASTY IMPLANTS TOTAL KNEE ARTHROPLASTY REVISION$33,273
- KNEE & HIP IMPLANTS PATELLOFEMORAL TENDON REPAIR$33,273
- ARTHROPLASTY INSTRUMENTS TOTAL KNEE ARTHROPLASTY TOTAL KNEE$21,446
- ARTHROPLASTY IMPLANTS KNEE ARTHROPLASTY UNI KNEE$20,672
- OMNIBotics 3.0$19,244
How this compares
$1,361,606 in reported general payments places this provider in the 95th percentile of 124 orthopaedic surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 318 | $2,213 |
| Diclofenac Sodium | 54 | $1,401 |
| Meloxicam | 358 | $968 |
| Tranexamic Acid | 163 | $810 |
| Ibuprofen | 36 | $455 |
| Gabapentin | 67 | $367 |
| Naproxen | 18 | $225 |
| Omeprazole | 158 | $163 |
| Mupirocin | 22 | $137 |
| Cyclobenzaprine Hcl | 11 | $37 |
| Amoxicillin | 22 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Wakefield
- Robert MarchandWakefield$1.4M
- Ian MadomWakefield$125K
- Anthony BuonannoJohnston$2M
- Alan DanielsEast Providence$1.9M
- Edward PaxtonProvidence$244K
- Valentin AntociEast Providence$210K
- Dominic KleinhenzEast Providence$164K
- Bassel DieboEast Providence$138K
- Steven BokshanProvidence$130K
- Christopher HutchinsWesterly$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.